AAV gene therapy for treating nervous system diseases

JP2025524548A5Pending Publication Date: 2026-06-30SINEUGENE THERAPEUTICS CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
SINEUGENE THERAPEUTICS CO LTD
Filing Date
2023-06-27
Publication Date
2026-06-30

Smart Images

  • Figure 00000025_0000
    Figure 00000025_0000
  • Figure 00000025_0001
    Figure 00000025_0001
  • Figure 00000025_0002
    Figure 00000025_0002
Patent Text Reader

Abstract

A recombinant adeno-associated virus (rAAV) expression vector comprising a gene encoding a TRIM72 protein or a variant or functional fragment thereof, wherein the recombinant AAV expression vector comprises a neuron-specific promoter, is provided. A pharmaceutical composition comprising the rAAV expression vector and its use are further provided.
Need to check novelty before this filing date? Find Prior Art